BUSINESS● LOW3h ago · Sep 8, 2026, 9:38 AM
Switzerland's Sandoz aims to double sales by 2035 in expanded biosimilars push
Seeking Alpha Tech · western europe
Switzerland's Sandoz aims to double its sales by 2035, driven by an expanded push into biosimilars. This indicates the company's long-term growth strategy within the pharmaceutical market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS30m agoBullish August trading volume rises 38% M/M as crypto volatility easesSeeking Alpha TechBUSINESS31m agoIonQ rises as it boosts guidance after SkyWater deal, launches Superion products, moreSeeking Alpha TechBUSINESS33m agoLiverpool change shirt sponsor for first time since 2010Vanguard NigeriaBUSINESS33m agoOil prices approach $100 as Middle East conflict flares, Goldman sees potential upside to $120Yahoo Finance